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Abstract 
Objectives: There are no commonly accepted standards for monitoring patients treated for head and 
neck cancer. The aim of this study was to assess patients’ preferences for different aspects of follow-
up.  
Methods: A best-worst survey was conducted in a sample of head and neck cancer patients in clinical 
follow-up at the National Cancer Institute (Milan, Italy). Conditional logit regression with choice as the 
dependent variable was run to analyse the data. A covariate-adjusted analysis was performed in order to 
identify socio-demographic and clinical factors related to the selection of best-worst items. The 
participants were asked to report any difficulties encountered during the survey. 
Results: A total of 143 patients, predominantly male (74%) and with a mean age of 58 years were 
enrolled in the survey. The strongest positive preference was expressed for a hospital-based program of 
physical examinations with frequency decreasing over time. Conversely, the lowest valued item was 
not performing any positron emission tomography (PET) scan during follow-up. Patients with high 
educational levels were more likely to value attending a primary care-based program and undergoing 
intensive radiological investigations. Other patient-specific variables significantly associated with the 
choice of items were employment and living status, time already spent in follow-up and number of 
treatments received.  
Conclusions: Overall, patients were more likely to choose an intensive follow-up scheme broadly 
consistent with the program currently administered by the hospital. There is little evidence of 
preference heterogeneity that might justify customized programs based on demographics. The best-
worst scaling task appeared feasible for most participants. 
Introduction 
Head and neck cancer (HNC) is the sixth most common cancer in the world with nearly 700,000 new 
diagnoses and 370,000 deaths reported each year [1,2]; incidence in Italy has been assessed at 7.7 cases 
per 100,000 [3]. HNC consists of a heterogeneous group of malignancies affecting several anatomical 
sites and with different prognoses [4]. The main risk factors are alcohol and tobacco abuse and, in 
recent years, the infection with human papilloma virus (HPV) for cancers located in the oropharynx 
[1]. The risk of relapse is greater in the first two years after primary treatment, when an estimated 50-
60% of patients develop loco-regional recurrences or metastases [1]; lifetime risk of second primary 
cancers is around 10-20% (i.e. 2%-5% per year) [5]. Therefore, a follow-up program is essential shortly 
after the completion of treatment in order to identify potentially curable relapses. However, the optimal 
timing of visits and radiological assessments following treatment is debated by oncologists. Published 
recommendations are mostly informed by retrospective studies, expert opinions and clinical practice 
rather than trial-based evidence [2,5]. Until now, no consensus has been reached on the optimal follow-
up modalities and timing in HNC patients. 
In addition to this clinical uncertainty, the patient’s perspective has traditionally been neglected in 
designing cancer programs and elaborating clinical guidelines, whilst considering individual 
preferences might improve the feasibility, acceptability and effectiveness of healthcare interventions 
[6]. This is part of a larger study evaluating the cost-effectiveness of different surveillance schemes in 
HNC [HETeCo, clinicaltrials.gov identifier NCT02262221]. The current objective is to quantify 
preferences for post-treatment surveillance in a large sample of patients treated for primary HNC.  
Methods 
This study used best-worst scaling (BWS) to elicit patient’s preferences for different aspects of follow-
up after primary treatment for HNC. 
Experimental design 
The BWS choice experiment is a variant of the widely adopted binary choice experiment approach. As 
in traditional discrete choice experiments (DCEs), this method requires the identification of key 
characteristics (i.e. the attributes) each of which is split into two or more levels, in order to create a 
series of scenarios described by different attribute-level combinations. However, instead of selecting 
one scenario in a choice set of two or more, participants are asked to indicate which attribute-level they 
consider to be the ‘best’ and which to be the ‘worst’ (i.e. the BW pair) within each scenario. In other 
words, they choose ‘the pair that exhibits the largest perceptual difference on an underlying continuum 
of interest’ [7,8]. There exist three types of BWS studies in the literature: the object case (case 1), the 
profile or attribute case (case 2), and the multi-profile case (case 3) [9]. The present study used the 
profile case in which participants are presented with a series of different scenarios to be evaluated one 
at a time. 
Our analysis was limited to the process-related aspects of the follow-up [10], as clinical outcomes of 
post-treatment surveillance in HNC are still under debate in the scientific community. Relevant 
attributes and levels were established from literature review and expert opinion. We searched common 
databases (PubMed and EMBASE) using key terms such as “cancer” AND “follow up” AND “discrete 
choice experiment” (OR “best worst”) in title/abstract in order to identify studies that assessed patient’s 
preferences around post-treatment programs in oncology using stated preference methods. Interviews 
with six patients during routine hospital visits were used to refine terminology and evaluate the 
comprehension and the acceptability of the BWS instrument.  
After this preliminary work, we eventually identified four attributes: frequency and setting (hospital or 
mixed with primary care) of physical investigations; frequency of radiological assessments (magnetic 
resonance imaging - MRI or computed tomography - CT); frequency (and eligibility) of positron 
emission tomography (PET) scans; telephone calls to monitor the occurrence of new symptoms. Levels 
were presented in order of increasing intensity of care and resources consumption for each attribute 
(Table 1). A balanced study design was adopted in which each study attribute (K=4) had the same 
number of levels (LK = 3). If an alternative contains K attributes, there are K (K-1) = 4 (4-1) = 12 
possible BW pairs the participant can choose within each scenario. As a full factorial design generating 
all possible attribute-level combinations (34 = 81 scenarios) was not feasible, a subset of 9 orthogonal 
scenarios (fractional factorial, main-effects design) was derived using the Hann and Shapiro catalogue, 
Master Plan 3 [11]. The total number of BW pairs in the orthogonal design was 108 (12∙9). This sub-
group of selected scenarios preserved the properties of orthogonality (i.e. each attribute-level appears 
an equal number of time in combination with all other attribute-levels) and balance (i.e. each level 
within an attribute appears an equal number of times) [12,13]. 
Recruitment and setting 
Patients aged 18 years and over, with a diagnosis of HNC in any anatomical site (except for the skin) in 
the last 5 years, who had completed any curative treatment at the National Cancer Institute (NCI) in 
Milan were eligible to participate. Patients were excluded if they were unable to comply with the study 
in the opinion of the clinical investigators, or they could not provide their informed consent. Moreover, 
we excluded patients who underwent minor surgery for early stage cancer and subsequently did not 
attend a regular follow-up program in a multidisciplinary setting, i.e. with the contemporary presence 
of the head and neck surgeon, the radiation oncologist, and the medical oncologist. At NCI, the routine 
follow-up program consists of outpatient visits every 2-3 months for the first 2 years after the end of 
treatment, then every 5-6 months for 3 more years. Radiological evaluations with MRI/CT scan are 
performed once 3 months after the end of treatment, then annually. PET is requested only in the case of 
doubtful imaging; no scheduled inter-visit contact is planned during the follow-up period. 
The study was described to a consecutive sample of eligible patients during a routine follow-up 
appointment. Patients were reassured that responses to the questionnaire would not affect the care they 
were receiving at the hospital [14]. Those who agreed to participate were asked to sign a consent form 
and received the survey. Socio-demographic and clinical information were collected for each study 
participant. The questionnaire included a short rationale for the study and an explanation of the task 
required. The study was approved by the NCI Ethical Committee in March 2015; the survey was 
subsequently administered between May and October of the same year.  
Statistical analysis 
Data on patients’ characteristics were summarized through descriptive statistics; categorical variables 
were presented as percentages while continuous variables were presented as means and standard 
deviations. In regression analyses, missing demographic data were imputed using logical rules and 
information from related variables or, whenever this approach was not feasible, the most common 
value (i.e. the mode) [15]. Missing BW responses were imputed with the items most frequently selected 
as best and worst respectively within each scenario. The number of times each item was chosen as 
‘best’ or ‘worst’ by the study participants was calculated. A best-minus-worst score was calculated by 
subtracting the number of times a feature was chosen as worst from the number of times it was chosen 
as best [6,14]. 
Regression analysis was performed using a conditional logit model (clogit command in Stata) with 
cluster-adjusted (robust) standard errors [16]. BW pairs were treated as single variables and plotted as 
one data point at the individual level [17]. For each possible pair, the attribute-level was coded as 1 for 
the best and -1 for the worst; all remaining attribute-levels were coded as 0. The dependent variable 
took the value of 1 for the BW pair selected and 0 otherwise. In order to avoid a saturated model, the 
item that showed the lowest utility was used as reference level; the omitted item took the value of zero 
on the utility scale and all estimates of the model were interpreted in relation to that. Therefore, each 
attribute-level can be positioned on an underlying preference scale (0; +∞) starting with the reference 
item [9,18]. Statistically significant coefficients indicated the importance of the attribute-level in 
determining overall utility [19]. 
A covariate-adjusted analysis was also performed to investigate sub-group preferences according to 
socio-demographic and clinical characteristics. A conditional logit model was run as previously 
described; however, interaction factors between selected covariates and choice outcomes (i.e. attribute-
levels) were also added as independent variables [16]. In this model, interaction coefficients represent 
the additional utility of each attribute-level for the covariate [6]. A preliminary univariate regression 
analysis was performed to identify the demographic variables to be included in the final covariate-
adjusted model as those displaying significant interaction terms (p<0.05). Variables with three (or 
more) categories in the questionnaire were dichotomized to increase the sample size within each group. 
Two age classes were generated around its median value (59 years) [6]. With regards to the clinical 
variables, the number of treatments received (i.e. one vs. more than one) was chosen as a ‘proxy’ of 
disease severity that, according to the clinicians involved in the study, might influence patient’s 
preferences in follow-up; the time from the end of treatments was equally considered clinically 
relevant. Any other clinical information was disregarded in this analysis. 
All data were analyzed using Stata version 14 (Stata Corp, 2015). 
Results 
Sample characteristics 
A total of 162 consecutive patients who met the inclusion criteria were approached to participate in the 
survey; however, sixteen declined resulting in a response rate of 90%. Three questionnaires were 
excluded from data analysis, as they were not completed correctly or in full. Therefore, the final sample 
comprised 143 patients, of whom 74% were male. Socio-demographic and clinical features of the 
participants are presented in table 2. The mean age of participants was 57.6 (±12.1) years and more 
than one third of patients were retired (34.2%). The great majority of patients (85.3%) lived with 
family and 64.3% less than 100 km from the hospital.  
A variety of primary tumor diagnoses were observed in the sample, with the most common being 
oropharyngeal (38.4%), nasopharyngeal (28.0%) and laryngeal cancer (11.2%), mostly in a locally 
advanced stage (III and IV; 93.7%). Most patients (38.5%) received a combination of chemotherapy 
and radiation as primary treatment for HNC, or chemotherapy followed by the combined therapy 
(30.0%). Participants were equally distributed according to time since the end of treatments as follows: 
≤2 years, 51.0%; >2 years, 49.0%.  
BWS frequency counts 
Frequency counts provide summary estimates of best and worst choices made by participants (Table 3). 
Of a total of 2,574 expected BW responses, only 12 (0.5%) were missing and imputed as previously 
explained. The highest ranked attribute-level was “physical investigations performed every 2-3 months 
for 2 years, then every 5-6 months for 3 more years”. The lowest rated feature is less clearly 
identifiable. According to the best-minus-worst score, the lowest valued attribute-level was “inter-visit 
calls by the nurse” to monitor patient’s health status. “No PET scan during follow-up” was the item 
least frequently chosen as “best”, while “primary care-based follow-up during the last 2 years” was that 
most often indicated as “worst”.  
Conditional logistic regression analysis 
The logistic regression results are presented in table 4. The attribute-level with the lowest utility 
coefficient was “not performing any PET scan during follow-up” and was assumed as the reference 
level. The regression coefficients of BW pairs show the additional utility of each attribute-level over 
the reference case. As already observed in frequency counts, the feature showing the highest utility was 
“physical investigations performed every 2-3 months for 2 years and every 5-6 months for 3 more 
years”. A more intensive frequency of visits (“every 2-3 months for 5 years”) ranked second, and 
“MRI/CT scan performed once or twice a year” ranked third. In contrast, the attribute-levels with the 
lowest utility were “follow-up based at primary care during the last 2 years”, “inter-visit calls by the 
nurse” and “no inter-visit calls from the hospital” in that order; however, none of them was statistically 
significant compared to the reference level.  
For each individual attribute, the distance between the most and the least preferred levels is an 
indication of the relative importance of that attribute to respondents [9,18]. In this survey, the 
“frequency and setting of physical and larynx/pharynx endoscopic investigations” is the item with the 
largest difference between level coefficients (2.482 i.e. 2.523 minus 0.041) and, thus, the greatest 
impact on patients’ utilities. Summing the level coefficients taken one at a time within each attribute, it 
is possible to calculate an overall utility for each hypothetical follow-up scheme deriving from the 
experiment. The most preferred scenario (overall utility: 6.120) across the sample would be a hospital-
based follow-up with frequency of visits decreasing over time (i.e. every 2-3 months for 2 years, every 
5-6 months for the next 3 years), radiological assessments (i.e. MRI/CT) performed once or twice a 
year, yearly PET scan for all patients (irrespective of individual risk of recurrences) and inter-visit calls 
by the oncologist to monitor the occurrence of new symptoms. On the contrary, the least desirable 
option is a mixed hospital-/primary care-based surveillance with MRI/CT scan performed only at the 
occurrence of new symptoms, no PET scan scheduled during follow-up period and inter-visit calls by 
the nurse to check the patient’s health (scenario utility: 0.654). 
Covariate-adjusted regression analysis 
Table 5 provides results from the conditional logistic regression analysis after adjusting for selected 
clinical and demographic data. Educational level (more educated i.e. university, post-university =1; less 
educated i.e. primary school, secondary school =0), employment status (employed i.e. full-time 
employed, part-time employed, self-employed =1; not employed i.e. retired, unemployed, other =0), 
living status (with family=1; alone =0), time in follow-up (>2 years =1; ≤2 years =0) and number of 
treatments (≥1 i.e. 2, 3 or 4 =1; one only =0) which displayed significant interactions in univariate 
regression analysis (Tables S1-S8) were included in the final model. Conversely, no significant 
interaction coefficients were found with respect to age (age≥59 =1; age<59 =0), gender (female =1; 
male =0) and distance from home (≥100 km =1; <100 km =0).  
The interpretation of regression results is facilitated through the example of education. There were 
statistically significant differences between education groups with respect to three of the four attributes 
in the experiment. The total utility of “MRI/CT scan performed once or twice a year” for highly 
educated patients is the sum of the attribute-level coefficient (1.590) and its interaction term coefficient 
with educational level (0.756), which gives 2.346. The corresponding utility for less educated people is 
the coefficient without interaction (1.590). Thus, we can infer that all patients like a more intensive 
radiological investigations program; however, this preference is stronger for those with more education. 
Furthermore,  highly educated patients are more likely to prefer a primary care based follow-up than 
those with a lower education level. The total utility of this item, indeed, is equal to 1.878 for the 
former, while not significantly different from the reference value for the latter (0.178). The last 
significant interaction is with “no PET scan during follow-up”; the overall utility for more educated 
patients is 0.201 whilst not significantly different from zero for the less educated ones.  
In a similar way, it is possible to calculate separate utilities for different groups of patients according to 
the remaining four covariates selected within the univariate analysis.  
Patients’ evaluation of the experiment 
Table 6 presents data on patients’ self-reported difficulties in understanding and completing the 
questionnaire. The average compilation time was 9.2 (± 3.1) minutes. Nearly half of the participants 
rated the BWS task very easy to perform (i.e. level 1; 45.4%) and did not need any support from 
healthcare professionals or family members (44.7%). More than one-third (37.1%) reported no 
difficulties during completion among the options available; “understanding the task” was the most 
common difficulty (21.7%) followed by “length of the questionnaire” (6.3%) and “technical/scientific 
language” (5.6%). A further 14% indicated other difficulties mainly related to indecision in selecting 
the BW pair and the feeling that scenarios were too repetitive.  
Discussion 
Few studies have explored patient’s preferences for delivery of post-treatment cancer programs and 
even fewer have attempted to derive utility estimates from them. A non-systematic literature review 
identified two binary DCE studies [20,21] exploring women’s preferences for breast cancer follow-up 
services in the Netherlands and Australia, respectively. Face-to-face contacts were strongly preferred to 
telephone ones and a more intensive program of visits (every 3-6 months) was preferred over the less 
intensive options. Moreover, women liked to be followed-up by a medical specialist and at specialized 
breast cancer clinics. A BWS study of post-treatment surveillance for soft tissue sarcoma in the UK 
concluded that patients typically preferred visits routinely consisting of a clinical examination and a 
chest X-ray, and secondary care- rather than general practice-based programs [17]. A further study [6] 
adopting the BWS methodology was identified even if not strictly related to follow-up but addressing a 
symptom supporting care intervention in lung cancer patients after completion of first line therapies. 
With respect to HNC, a non-DCE survey only on patients’ view of their follow-up regimen was 
conducted in UK. The study revealed that most patients felt their follow-up visits too frequent and were 
in favor of a less-intensive, symptom-driven follow-up [22].  
The BWS method is argued to have several advantages over traditional DCEs [6,18]. First, respondents 
are provided with profiles one by one rather than two (or more) at a time; thus, BWS is considered less 
cognitively demanding for participants [8,16,19,23]. These expectations were confirmed in our study 
by the self-reported judgement on the choice task, which was graded as simple and quick by the 
majority of respondents. Moreover, BWS may elicit more information than traditional DCEs, as 
respondents make choices within profiles rather than between profiles; in particular, in BWS a single 
attribute-level combination acts as benchmark, instead of a whole scenario. In this way, it is possible to 
calculate utility coefficients for each item in the experiment, which may be useful in evaluating 
different elements of a healthcare service [8,16,19,23]. Profile-based (case 2) BWS was selected in 
preference to the traditional pair-wise DCE because it was anticipated that patients would always select 
the option which they thought would maximize survival and consequently less information would be 
generated by responses to the pair-wise choice task. 
This study is the first stated preference survey of HNC follow-up and, in Italy, of any cancer 
surveillance. The survey aimed at providing insights into patients’ views on post-treatment monitoring 
in this cancer population using BWS methodology. Moreover, a covariate-adjusted analysis was 
performed to investigate socio-demographic or clinical characteristics related to the choice of attribute-
levels. It was not surprising to find that patients’ preferences for HNC follow-up were generally aligned 
with the scheme currently adopted by NCI where the study was conducted. This tendency has been 
described as the ‘lure of the familiar’ [17], meaning that individuals are likely to stick with they have 
already experienced, even if potentially unsatisfactory. Participants in this study revealed clear 
preferences for follow-up to remain in secondary care, even during the last phases of the program. 
Intensive radiological examinations (once or twice a year) were strongly preferred. Inter-visit telephone 
calls were generally disliked, especially when performed by healthcare professionals other than 
medical doctors. These results are in contrast with those found by a previous study on patients’ 
preferences in HNC follow-up [22]; however, that survey was conducted in a different geographical 
setting (highly deprived areas of London) and without relying on stated preference methods. 
Differences in preferences according to individual characteristics were also found. Overall, highly 
educated patients were more likely to prefer primary-care based follow-up and intensive MRI/CT 
radiological investigations but avoiding PET scan. Patients with a job tended to prefer more frequent 
visits to the hospital but no inter-visit calls, while those living with family revealed a stronger 
preference for not performing any PET scan during follow-up. Patients two years (or more) following 
treatment expressed a lower utility for more intensive MRI/CT investigations and were keener to avoid 
inter-visit telephone calls with their clinicians. Patients who had received more than one treatment 
option (e.g. surgery followed by radiotherapy) were less keen to accept a symptom-driven radiological 
surveillance and to travel frequently to the hospital for physical investigations. Conversely to a 
previous study [6], we found no differences in age or gender with regards to preferences for delivering 
a post-treatment intervention in cancer care; however, the program under evaluation was considerably 
different. 
This study has a number of limitations. First, the data collection was restricted to only one center that, 
due to some distinctive features (i.e. high specialization, commitment to research, cutting-edge 
technologies), may not be representative of a typical cancer clinic in Italy. Moreover, patients attending 
NCI, especially those coming from afar, are likely to be more educated, wealthy or health conscious 
than the general HNC population. However, the referral to a single center reduced bias related to 
different ways of administering the survey and providing support during the completion of the 
questionnaire. Second, the cognitive ability of each participant with respect to completing the task was 
not evaluated and in some occasions the patient was supported by the accompanying person. 
Nevertheless, given the very low number (n=3) of questionnaires excluded from the analysis and the 
limited self-reported difficulties, we are confident that the task was feasible for most participants. The 
final limitations concern the restricted range of hypothetical follow-up programs that can be valued 
owing to the small number of attributes-levels and the assumption of no interaction between BWS 
items. However, the limited number of items included in the experiment, as well as the use of a small 
factorial main-effects design (i.e. 9 out of 81 scenarios), was justified by feasibility considerations. 
In recent years, there has been growing interest in using preference elicitation methods to inform health 
policy and medical decision-making. Incorporating patient’s preferences into the treatment and follow-
up strategies may help in tailoring healthcare to the patient and increase adherence to treatment [24]. In 
HNC follow-up, patients seem to be reassured by a regular follow-up with scheduled imaging and 
expertise of specialists, as already reported in other experiences [25]. The present study highlighted 
patients’ limited interest in alternative ways of delivering post-treatment services, such as symptom-
driven surveillance, telephone monitoring or non-specialist follow-up. Healthcare professionals (e.g. 
general practitioners or nurses) other than specialist doctors were probably considered not skilled 
enough to conduct cancer follow-up. There might be a resistance to change from established to new 
types of service without adequate reassurance from the clinicians. In particular, patients with less 
education may benefit least from a patient-initiated follow-up owing to difficulties in understanding 
medical instructions. Overall, there is a need for improved communication for cancer patients to 
evaluate consciously the post-treatment phase and to promote self-managed symptoms monitoring [26]. 
Patients likely prefer intensive radiological assessment because of fear of disease recurrence; however, 
tests should be performed for clinical reasons and not (only) for patient’s reassurance. The long-term 
effects associated with frequent and prolonged radiological scans should also be considered. In this 
regard, more efforts should be spent in order to identify the most cost-effective follow-up scheme in 
HNC, thus providing the scientific community and patients with evidence-based programs. A 
randomized trial comparing health and economic outcomes in this setting is ongoing [HETeCo, 
clinicaltrials.gov identifier NCT02262221]. Finally, differences in preferences were found according to 
the intensity of treatments received and the time already spent in follow-up; these results might justify a 
provision of different surveillance schemes based on these clinical variables, as already suggested by 
guidelines in the field [27]. Similarly, inter-visit calls appear to be more valuable in the initial phases of 
the follow-up than in the final ones, when patients may feel more confident of beating cancer. 
Overall, this study provided useful insights into individual preferences for several aspects of post-
treatment surveillance in HNC in Italy. Additional elements might be explored in the future, such as the 
level of scientific evidence, co-payment for extra-investigations and late side effects of intensive 
investigations. Currently, there is evidence of heterogeneity in preferences with respect to a limited 
number of patient’s characteristics. More research also considering the costs of different follow-up 
regimens is required to justify the provision of customized follow-up programs in HNC patients.  
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